UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Covid Vaccine Makers’ Stocks Crash To Multiyear Lows Monday As Sales Keep Sliding

Forbes Moderna and BioNTech shares both cratered to their lowest price in years Monday as the companies behind the most widely-circulated mRNA Covid-19 vaccines grapple with investor disappointment with crashing revenues.

BioNTech and Moderna’s stocks fell 8% and 6%, respectively, a decline spurred by BioNTech’s earnings report revealing the German firm’s sales fell 95% year-over-year last quarter.

Moderna’s fresh decline came after it reported a 93% annual decline in quarterly revenues in its own earnings release Thursday.

Moderna’s $101.20 close Monday was its lowest since November 2020, while BioNTech’s $98.50 close was its lowest since March 2021.

Continue reading

twitter facebook bluesky email print

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.